A 66-year-old New Hampshire man with end-stage kidney failure lived without dialysis for a record-breaking 271 days after receiving a genetically modified pig kidney. Transplanted in January 2025 at Mass General Brigham, the organ functioned immediately, marking a major milestone in xenotransplantation research to bridge the severe human organ shortage.
In Plain English: The Clinical Takeaway
- Xenotransplantation: The process of transplanting organs or tissues from one species—in this case, a Yucatan miniature pig—into a human body.
- Dialysis-Free Survival: Living without needing a mechanical blood-filtering machine to perform the work of failed kidneys.
- Bridge Therapy: Utilizing an alternative organ temporarily to keep a patient stable while they wait for a compatible human donor organ.
The Clinical Milestone and Patient Journey
Tim Andrews lived successfully for nine months with a genetically edited pig kidney before transitioning to a short period of dialysis and eventually receiving a donor human kidney, according to findings published in The Lancet medical journal and reported by The Guardian and The Independent. Andrews suffered from end-stage kidney failure brought on by type 2 diabetes.
The Yucatan miniature pig organ underwent genetic engineering to improve compatibility with the human immune system. During the 271-day period, medical teams monitored the patient closely, confirming that no porcine viruses or other pig pathogens were detected at any point.
“The organ shortage is the greatest crisis we have right now in transplantation,” said Dr. Leonardo Riella, lead author of the study from the center for transplantation sciences at Mass General Brigham, as reported by The Independent. “We know that the best treatment option for patients with end-stage kidney disease who have developed renal failure is transplantation, but we simply don’t have enough human organs to transplant in a timely manner.”
Understanding the Mechanics of Porcine-to-Human Transplants
The primary barrier to successful xenotransplantation involves immune system dynamics.
After roughly six months, damage developed within the kidney’s blood vessels. This vascular injury progressively worsened into organ failure, leading the clinical team to remove the pig kidney and place Andrews back on temporary dialysis before his subsequent human kidney transplant. Researchers highlighted this progression as vital data for understanding the long-term durability of gene-edited organs.
Regulatory Frameworks and Public Health Access
The procedure was performed in the United States.
| Clinical Parameter | Patient Details & Outcome |
|---|---|
| Patient Profile | Tim Andrews, 66, New Hampshire |
| Primary Diagnosis | End-stage renal failure secondary to type 2 diabetes |
| Organ Source | Genetically modified Yucatan miniature pig |
| Duration of Function | 271 days (approximately nine months) without dialysis |
| Primary Complication | Progressive blood vessel damage after six months leading to organ removal |
| Pathogen Monitoring | Zero porcine viruses or pathogens detected |
Contraindications & When to Consult a Doctor
Xenotransplantation remains an experimental investigational procedure rather than a standard clinical option.
Patients experiencing chronic kidney disease must adhere strictly to established nephrology guidelines. Any acute signs of fluid retention, severe fatigue, oliguria (decreased urine output), or sudden electrolyte imbalances warrant immediate consultation with a qualified nephrologist.
References
Disclaimer: This article is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
